Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
71.3M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
42.3M
-
Shares change
-
+3.23M
-
Total reported value, excl. options
-
$1.39B
-
Value change
-
+$101M
-
Put/Call ratio
-
0.06
-
Number of buys
-
87
-
Number of sells
-
-37
-
Price
-
$32.79
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q4 2022
144 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q4 2022.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.3M shares
of 71.3M outstanding shares and own 59.37% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (3.77M shares), venBio Partners LLC (3.46M shares), Capital International Investors (2.11M shares), BlackRock Inc. (1.97M shares), LORD, ABBETT & CO. LLC (1.84M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.81M shares), FMR LLC (1.69M shares), RTW INVESTMENTS, LP (1.55M shares), VANGUARD GROUP INC (1.5M shares), and JANUS HENDERSON GROUP PLC (1.46M shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.